Home > Insider Trading > Filing (0000902664-21-001964)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
316253	Enzo Biochem Inc	ENZ	Services-Medical Laboratories (8071)	132866202

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1233571	J Raymond Harbert	2100 Third Avenue North Suite 600 Birmingham AL 35203	No	No	Yes	No
1259933	Harbert Management Corp	2100 Third Avenue North Suite 600 Birmingham AL 35203	No	No	Yes	No
1616659	Harbert Fund Advisors, Inc.	2100 Third Avenue North Suite 600 Birmingham AL 35203	No	No	Yes	No
1626127	Harbert Discovery Fund, Lp	Harbert Discovery Fund Gp, Llc 2100 Third Avenue North, Suite 600 Birmingham AL 35203	No	No	Yes	No
1642336	F. John Bryant	C/O Harbert Management Corporation 2100 Third Avenue North, Suite 600 Birmingham AL 35203	No	No	Yes	No
1642389	Kenan Lucas	C/O Harbert Management Corporation 2100 Third Avenue North, Suite 600 Birmingham AL 35203	No	No	Yes	No
1642538	Harbert Discovery Fund Gp, Llc	2100 Third Avenue North Suite 600 Birmingham AL 35203	No	No	Yes	No
1771491	Harbert Discovery Co-Investment Fund I, Lp	2100 Third Avenue North Suite 600 Birmingham AL 35203	No	No	Yes	No
1771499	Harbert Discovery Co-Investment Fund I Gp, Llc	2100 Third Avenue North Suite 600 Birmingham AL 35203	No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, $0.01 Par Value ("Common Stock")	Disposition	2021-03-15	100,000	$4.75	5,520,681	No	4	S	Indirect	See footnote
Common Stock	Disposition	2021-03-15	44,768	$5.00	5,475,913	No	4	S	Indirect	See footnote
Common Stock	Disposition	2021-03-16	200,000	$4.70	5,275,913	No	4	S	Indirect	See footnote
Common Stock	Disposition	2021-03-16	100,000	$4.54	5,175,913	No	4	S	Indirect	See footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	See footnote
No	4	S	Indirect	See footnote
No	4	S	Indirect	See footnote
No	4	S	Indirect	See footnote

Footnotes

The securities reported herein are held by Harbert Discovery Fund, LP (the "Discovery Fund") and Harbert Discovery Co-Investment Fund I, LP (the "Discovery Co-Investment Fund" and together with the Discovery Fund, the "Funds"). Harbert Discovery Fund GP, LLC ( the "Discovery Fund GP") is the general partner of the Discovery Fund, and Harbert Discovery Co-Investment Fund I GP, LLC is the general partner of the Discovery Co-Investment Fund (and together with Harbert Discovery Fund GP, the "Fund GPs"). Harbert Fund Advisors, Inc. is the investment adviser to the Funds. Harbert Management Corporation ("HMC") is the managing member of the Fund GPs. Jack Bryant is a Senior Advisor to the Discovery Fund, and a Vice President and Senior Managing Director of HMC. Kenan Lucas is the managing director and portfolio manager of the Funds. Raymond Harbert is the controlling shareholder, Chairman and Chief Executive Officer of HMC.